Published in April 2010 – The Global State of Harm Reduction 2010: Key Issues for Broadening the Response – is the second major report in the series. It provides a region-by-region update of key developments in harm reduction since the first Global State report was released in 2008. It also explores several issues key to the response to drug-related harms worldwide, including increasing access to harm reduction in prisons and other places of detention, reaching people who use drugs with diagnosis, treatment and care for viral hepatitis and tuberculosis, preventing overdose-related mortality among people who use drugs, preventing and treating injecting-related bacterial infections, expanding the response to harms related to amphetamine use and addressing the current shortage of funds for harm reduction worldwide.
It is designed to be an advocacy and reference tool for a wide range of audiences, including international donor organisations, multilateral and bilateral agencies, non-governmental and community-based organisations, including organisations and groups of people who use drugs, researchers and the media.
The report is the result of collaboration between Harm Reduction International’s Public Health Research and Policy programme and harm reduction networks, researchers, and organisations of people who use drugs, whose input is essential to reflecting the situation around the world. In addition, chapters on key issues for harm reduction were contributed by experts from civil society, academia and multilateral agencies.
Click here to download the report - (warning very large file)
Alternatively, the report can be downloaded in sections:
Click here to view the introduction of the report
Section 1 provides a global overview of harm reduction policy and programming.
Section 2 contains nine regional updates which examine the developments for harm reduction since 2008 in Asia, Eurasia, Western Europe, the Caribbean, Latin America, North America, Oceania, the Middle East and North Africa, and Sub-Saharan Africa.
GSHR 2010 - Middle East and North Africa
Section 3 explores issues that are key to broadening the global harm reduction response.
3.1 The silent epidemic: Responding to viral hepatitis among people who inject drugs
3.2 Enhancing synergy: Responding to tuberculosis epidemic among people who use drugs
3.4 Speeding up the response: A global review of the harm reduction response to amphetamines
3.5 Out of sight, out of mind? Harm reduction in prisons and other places of detention
3.6 Underestimated and overlooked: A global review of drug overdose and overdose prevention
3.7 Bridging the gap: An analysis of global spend and resourcing need for harm
